The addition of concurrent cisplatin to adjuvant radiation therapy conferred no benefit to women with intermediate-risk, ...

Last November, results from the MITIGATE trial made headlines at ACR Convergence 2024 with positive phase 3 trial data for inebilizumab, an IgG1 monoclonal antibody targeting CD19, in patients with ...

Madness in men’s and women’s college basketball kicks off, millions will tune in to watch and bet — with the latter having ...

A slow immune response to SARS-CoV-2 infection, delayed viral clearance, and viral rebound can all increase a person’s risk ...

The AGA reported that it could not issue a recommendation for or against the use of computer-aided detection in colonoscopy ...

Flash photos typically produce a red reflection in people’s eyes, but sometimes that reflection can appear white or gray, ...

Individuals in Canada who received hospital care for hallucinogen use had greater 5-year mortality risk, especially from ...

A long time ago, my kids taught me that the importance of pain depends upon whether you are the one giving it or the one ...

Machine learning may help identify biomarkers and develop predictive models that could assist in the diagnosis of metabolic ...

The CMS End-Stage Renal Disease Treatment Choices model was designed to offer optimal care while cutting Medicare expenses, ...

Risk for moderate to severe depressive symptoms during pregnancy varied widely across 20 different racial and ethnic groups, ...

Having COVID-19 pneumonia vs. non-COVID-19 pneumonia while receiving extracorporeal membrane oxygenation negatively impacted ...